Biochemical analysers to move out of the lab:
This article was originally published in Clinica
The emergence of next-generation biochemical analysers has edged a step closer, as The University of Texas MD Anderson Cancer Center closed a commercial and development deal with Applied MEMS, specialists in micro-electrical mechanical systems. The collaborators plan to develop a handheld, portable device that integrates fluidics, optics and sensing techniques onto a single silicon chip, reducing the cost and inconvenience associated with laboratory-based equipment. Applied MEMS, of Stafford, Texas, will develop and manufacture the micro-fluidic processor chips, while aDEPtas, a spin-off from MD Anderson, will commercialise the product.